• 11/21/06
Progenitor Cell Therapy to Host Seminar at Phacilitate Cell & Gene Therapy Forum 2007

Integrated Solutions for Accelerated Development of Cellular Therapies

Sponsored by Progenitor Cell Therapy LLC. Co-hosted by BD Biosciences, Invitrogen, & Wave Biotech.

Providing technical insight and case histories, this seminar series will focus on some of the leading technologies that can be applied to the manufacture and characterization of cellular therapies in order to accelerate the product development cycle.

Key areas to be addressed will include strategies and tools for the:

• Selective depletion or enrichment of target cell populations
• Activation of target cell populations
• Culture expansion of target cell populations
• Development of potency assays for cellular therapies
• Quality control testing of cellular therapies
• Biological characterization of cellular therapies

The seminar participant will better understand:

• Cutting edge technologies available for cell separation, cell expansion and cell characterization
• Strategies to integrate and apply available tools and technology to:
• Optimize manufacturing processes early in the product development cycle
• Provide a seamless path to scale-up manufacturing from Phase I clinical trials through commercialization
• Simplify the regulatory pathway
  

Faculty

Chair:
Robert A. Preti, PhD, President and Chief Scientific Officer, Progenitor Cell Therapy LLC

Speakers/Panelists:
Stewart Craig, PhD, Vice-President and Chief Technical Officer, Progenitor Cell Therapy LLC
Amitabh Gaur, Ph.D., Director, Custom Technology Team, BD Biosciences
Øystein Åmellem, PhD, Segment Director, Dynal Bead Based Separations, Invitrogen Corporations
Daniella Kranjac, Ch.Eng., Vice President, Sales & Marketing, Wave Biotech